REG - CVS Group plc - Transaction in Own Shares
04/12/2025 07:00
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251204:nRSD1515Ka&default-theme=true
RNS Number : 1515K CVS Group plc 04 December 2025
04 December 2025
CVS GROUP plc
("CVS" or the "Company" and, together with its subsidiaries, the "Group")
Transaction in own shares
CVS announces that on 03 December 2025 it purchased the following number of
its ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg,
Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the
terms of the share buyback programme announced on 24 October 2025 (the "Share
Buyback Programme").
Date of purchase: 03/12/2025
Aggregate number of Ordinary Shares purchased: 24,653
Lowest price paid per share (GBp): 1,200.00
Highest price paid per share (GBp): 1,232.00
Volume weighted average price paid per share (GBp): 1,215.11
CVS intends to cancel all of the purchased Ordinary Shares.
Following settlement of the above purchases and cancellation of the Ordinary
Shares purchased, CVS will have 70,995,821 Ordinary Shares in issue and holds
no Ordinary Shares in treasury.
The total number of voting rights in CVS is therefore 70,995,821 and this
figure may be used by shareholders as the denominator for the calculations by
which they will determine if they are required to notify their interest in, or
a change to their interest in, CVS under the Financial Conduct Authority's
Disclosure and Transparency Rules.
Since the commencement of the Share Buyback Programme, the Company has
repurchased 744,962 Ordinary Shares in aggregate at a weighted average price
of 1,215.97 pence per share.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market
Abuse Regulation), as it forms part of Retained EU Law as defined in the
European Union (Withdrawal) Act 2018, the table below contains detailed
information of the individual trades made by Berenberg as part of the Share
Buyback Programme.
Individual transactions:
Number of Transaction price (GBp share) Time of Transaction Trading Venue
Ordinary Shares purchased transaction (UK Time) reference number
301 1232 03/12/2025 08:17:01 1344660387665002 XLON
98 1230 03/12/2025 08:17:16 1344660387665023 XLON
200 1226 03/12/2025 08:23:09 1344660387665656 XLON
600 1226 03/12/2025 08:23:57 1344660387665713 XLON
7 1226 03/12/2025 08:23:57 1344660387665714 XLON
7 1226 03/12/2025 08:23:57 1344660387665715 XLON
309 1224 03/12/2025 08:26:49 1344660387666086 XLON
91 1224 03/12/2025 08:26:49 1344660387666088 XLON
518 1220 03/12/2025 08:52:16 1344660387669367 XLON
71 1218 03/12/2025 08:52:18 1344660387669373 XLON
336 1222 03/12/2025 09:27:20 1344660387672055 XLON
538 1220 03/12/2025 09:44:19 1344660387673819 XLON
161 1218 03/12/2025 09:44:19 1344660387673822 XLON
155 1216 03/12/2025 09:44:25 1344660387673860 XLON
155 1214 03/12/2025 09:44:35 1344660387673876 XLON
14 1204 03/12/2025 09:57:10 1344660387674949 XLON
57 1204 03/12/2025 09:57:10 1344660387674950 XLON
98 1202 03/12/2025 09:57:36 1344660387675022 XLON
333 1200 03/12/2025 09:58:21 1344660387675072 XLON
66 1200 03/12/2025 09:59:44 1344660387675195 XLON
171 1200 03/12/2025 09:59:44 1344660387675196 XLON
540 1206 03/12/2025 10:16:47 1344660387676496 XLON
320 1206 03/12/2025 10:16:47 1344660387676500 XLON
16 1206 03/12/2025 10:16:47 1344660387676501 XLON
88 1208 03/12/2025 10:30:10 1344660387677723 XLON
72 1208 03/12/2025 10:30:10 1344660387677724 XLON
273 1206 03/12/2025 10:31:58 1344660387677854 XLON
308 1204 03/12/2025 10:48:44 1344660387679533 XLON
26 1204 03/12/2025 10:48:44 1344660387679534 XLON
20 1204 03/12/2025 10:48:44 1344660387679535 XLON
158 1202 03/12/2025 10:48:44 1344660387679539 XLON
76 1202 03/12/2025 10:48:44 1344660387679540 XLON
214 1202 03/12/2025 11:00:35 1344660387680842 XLON
426 1200 03/12/2025 11:39:46 1344660387684067 XLON
17 1204 03/12/2025 11:41:04 1344660387684147 XLON
54 1204 03/12/2025 11:42:01 1344660387684189 XLON
94 1216 03/12/2025 11:58:33 1344660387685190 XLON
399 1216 03/12/2025 11:58:33 1344660387685191 XLON
489 1214 03/12/2025 11:58:49 1344660387685210 XLON
89 1218 03/12/2025 12:13:36 1344660387686479 XLON
340 1218 03/12/2025 12:13:36 1344660387686480 XLON
1 1218 03/12/2025 12:13:36 1344660387686481 XLON
361 1218 03/12/2025 12:36:05 1344660387688270 XLON
103 1218 03/12/2025 12:36:05 1344660387688271 XLON
446 1216 03/12/2025 12:37:03 1344660387688342 XLON
456 1220 03/12/2025 12:38:17 1344660387688437 XLON
467 1220 03/12/2025 12:38:26 1344660387688450 XLON
467 1220 03/12/2025 12:41:17 1344660387688612 XLON
477 1220 03/12/2025 13:16:20 1344660387691562 XLON
478 1220 03/12/2025 13:17:00 1344660387691614 XLON
478 1220 03/12/2025 13:17:45 1344660387691738 XLON
255 1220 03/12/2025 13:17:45 1344660387691744 XLON
164 1220 03/12/2025 13:18:21 1344660387691847 XLON
320 1220 03/12/2025 13:18:21 1344660387691848 XLON
485 1220 03/12/2025 13:18:47 1344660387691937 XLON
486 1220 03/12/2025 13:18:47 1344660387691940 XLON
298 1218 03/12/2025 13:18:53 1344660387691956 XLON
240 1220 03/12/2025 13:19:42 1344660387692008 XLON
404 1220 03/12/2025 13:37:39 1344660387693706 XLON
258 1220 03/12/2025 13:37:50 1344660387693715 XLON
484 1220 03/12/2025 13:37:50 1344660387693722 XLON
484 1220 03/12/2025 13:38:00 1344660387693755 XLON
488 1220 03/12/2025 13:38:00 1344660387693761 XLON
488 1220 03/12/2025 13:38:14 1344660387693772 XLON
217 1220 03/12/2025 13:38:18 1344660387693778 XLON
56 1220 03/12/2025 13:38:29 1344660387693791 XLON
515 1220 03/12/2025 13:41:16 1344660387694081 XLON
510 1220 03/12/2025 13:42:02 1344660387694259 XLON
556 1220 03/12/2025 13:42:17 1344660387694297 XLON
598 1218 03/12/2025 13:42:22 1344660387694342 XLON
66 1216 03/12/2025 13:44:42 1344660387694571 XLON
176 1216 03/12/2025 13:47:14 1344660387694786 XLON
275 1216 03/12/2025 13:48:31 1344660387694944 XLON
37 1216 03/12/2025 13:48:31 1344660387694945 XLON
101 1216 03/12/2025 13:49:20 1344660387694988 XLON
94 1210 03/12/2025 14:21:47 1344660387698858 XLON
146 1210 03/12/2025 14:25:23 1344660387699122 XLON
33 1212 03/12/2025 14:34:14 1344660387701096 XLON
444 1212 03/12/2025 14:34:14 1344660387701097 XLON
444 1210 03/12/2025 14:35:43 1344660387701365 XLON
456 1210 03/12/2025 14:35:43 1344660387701369 XLON
555 1210 03/12/2025 14:48:23 1344660387703702 XLON
288 1210 03/12/2025 14:49:56 1344660387703947 XLON
568 1202 03/12/2025 14:50:09 1344660387704008 XLON
85 1204 03/12/2025 15:15:13 1344660387707930 XLON
592 1204 03/12/2025 15:23:51 1344660387709540 XLON
598 1202 03/12/2025 15:26:22 1344660387709926 XLON
71 1202 03/12/2025 15:31:03 1344660387710640 XLON
1 1202 03/12/2025 15:31:03 1344660387710641 XLON
146 1202 03/12/2025 15:36:27 1344660387711887 XLON
132 1202 03/12/2025 15:36:46 1344660387711967 XLON
Contacts
CVS Group
plc
via Camarco
Richard Fairman, CEO
Robin Alfonso, CFO
Paul Higgs, Chief Veterinary Officer
Charlotte Page, Head of Investor Relations
Peel Hunt LLP (Nominated Adviser & Joint Broker)
+44 (0)20 7418 8900
Christopher Golden / James Steel / Andrew Clark
Berenberg (Joint
Broker)
+44 (0)20 3207 7800
Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing
Camarco (Financial PR)
cvsg@camarco.co.uk
Ginny
Pulbrook
+44 (0)7961 315 138
Letaba Rimell
Tilly Butcher
About CVS Group plc (www.cvsukltd.co.uk)
CVS Group is an AIM-listed provider of veterinary services with operations in
the UK and Australia. CVS is focused on providing high-quality clinical
services to its clients and their animals, with outstanding and dedicated
clinical teams and support colleagues at the core of its strategy.
The Group now operates c.470 veterinary practices across its two territories,
including specialist referral hospitals and dedicated out-of-hours sites.
Alongside the core Veterinary Practices division, CVS operates Laboratories
(providing diagnostic services to CVS and third-parties) and an online retail
business ("Animed Direct").
The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and
c.3,300 nurses.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSUPGMWPUPAGMW
Copyright 2019 Regulatory News Service, all rights reservedRecent news on CVS
See all newsREG - CVS Group plc - Transaction in Own Shares
AnnouncementREG - CVS Group plc - Standard form for notification of major holdings
AnnouncementREG - CVS Group plc - Transaction in Own Shares
AnnouncementREG - CVS Group plc - Transaction in Own Shares
AnnouncementREG - CVS Group plc - PDMR Dealing
Announcement